Literature DB >> 6143870

Is cytomegalovirus infection a major cause of T cell alterations after (autologous) bone-marrow transplantation?

L F Verdonck, G C de Gast.   

Abstract

Peripheral-blood T cell subsets and functions were studied in 14 patients with malignancies treated with high-dose chemotherapy and radiotherapy followed by autologous bone-marrow transplantation (BMT). 8 CMV-positive patients (6 with latent infections and 2 with a primary infection) showed an inversion of the OKT4/OKT8 ratio caused by an increase in OKT8+ T cells and a decrease in OKT4+ T cells. This was accompanied by a pronounced increase in the percentage of HLA-DR + T cells, and functionally by increased suppressor T cell activity and decreased helper T cell activity and T cell proliferation. These alterations in T cell subsets and functions were not observed in 6 patients who were kept CMV-negative by a deliberate transfusion policy. In the 6 patients helper T cell activity and T cell proliferation capacity recovered well after day 30. Differences between the two groups were most striking 60 days after BMT. This study suggests that CMV infection, whether primary or secondary, is a major cause of T cell alterations after (autologous) BMT.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143870     DOI: 10.1016/s0140-6736(84)92391-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplantation.

Authors:  H Kook; F Goldman; R Giller; N Goeken; C Peters; M Comito; S Rumelhart; M Holida; N Lee; M Trigg
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

2.  Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantation.

Authors:  T Schmeiser; W Heit; R Arnold; D Bunjes; M Wiesneth; B Hertenstein; W Hampl; H Heimpel
Journal:  Klin Wochenschr       Date:  1987-10-15

3.  The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity.

Authors:  J W Gratama; M Kardol; A M Naipal; J Slats; A Den Ouden; T Stijnen; J D'Amaro; T H The; J W Bruning
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

4.  Phenotypic study of CD4+ and CD8+ lymphocyte subsets in relation to cytomegalovirus carrier status and its correlate with pokeweed mitogen-induced B lymphocyte differentiation.

Authors:  J W Gratama; R A Langelaar; M A Oosterveer; J A van der Linden; A den Ouden-Noordermeer; A M Naipal; J W Visser; G C de Gast; H J Tanke
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

Review 5.  Immune reconstitution following bone marrow transplantation.

Authors:  U N Verma; A Mazumder
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

Review 6.  Graft versus host diseases: new versions of old problems?

Authors:  A M Denman
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-02

7.  Pneumonitis in bone marrow transplant recipients results from a local immune response.

Authors:  H J Milburn; R M Du Bois; H G Prentice; L W Poulter
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

8.  Cytomegalovirus infection in cardiac transplant recipients associated with chronic T cell subset ratio inversion with expansion of a Leu-7+ TS-C+ subset.

Authors:  P Maher; C M O'Toole; T G Wreghitt; D J Spiegelhalter; T A English
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

9.  The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation.

Authors:  A M Würsch; J W Gratama; J M Middeldorp; C Nissen; A Gratwohl; B Speck; J Jansen; J D'Amaro; T H The; G C De Gast
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

10.  Changes in plasma beta 2 microglobulin concentrations after allogeneic bone marrow transplantation.

Authors:  D R Norfolk; M A Forbes; E H Cooper; J A Child
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.